Importance of some technical aspects of the procedure of percutaneous posterior tibial nerve stimulation in patients with fecal incontinence

2021 ◽  
Author(s):  
Rodolfo Rodríguez Carrillo ◽  
María Dolores Ruiz Carmona ◽  
Rafael Alós Company ◽  
Andrés Frangi Caregnato ◽  
Marina Alarcón Iranzo ◽  
...  
Keyword(s):  
Fecal Incontinence ◽  
Nerve Stimulation ◽  
Tibial Nerve ◽  
Posterior Tibial Nerve ◽  
Posterior Tibial Nerve Stimulation ◽  
Technical Aspects ◽  
Posterior Tibial ◽  
Tibial Nerve Stimulation

scholarly journals Posterior tibial nerve stimulation in the treatment of fecal incontinence: a systematic review

2018 ◽  
Vol 110 ◽  
pp. 577-588 ◽  
Author(s):  
Rubén Arroyo Fernández ◽  
Juan Avendaño Coy ◽  
Sara Ando Lafuente ◽  
M.� Teresa Martín Correa ◽  
Asunción Ferri Morales
Keyword(s):  
Systematic Review ◽  
Fecal Incontinence ◽  
Nerve Stimulation ◽  
Tibial Nerve ◽  
Posterior Tibial Nerve ◽  
Posterior Tibial Nerve Stimulation ◽  
Posterior Tibial ◽  
Tibial Nerve Stimulation

Effectiveness of percutaneous posterior tibial nerve stimulation for the management of bowel dysfunction in multiple sclerosis patients

2020 ◽  
pp. 135245852097226
Author(s):  
Rosaria Sacco ◽  
Andrea Braga ◽  
Giulio Disanto ◽  
Giuseppe Alessandro Digesu ◽  
Paolo Maino ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Fecal Incontinence ◽  
Nerve Stimulation ◽  
Tibial Nerve ◽  
Cleveland Clinic ◽  
Posterior Tibial Nerve ◽  
Posterior Tibial Nerve Stimulation ◽  
Posterior Tibial ◽  
Tibial Nerve Stimulation ◽  
Multiple Sclerosis Patients

Background: Neurogenic bowel dysfunctions (NBDs) in the form of both fecal incontinence (FI) and functional constipation (FC) are frequent in multiple sclerosis (MS) patients and significantly affect their quality of life. Therapeutic options are limited. Objective: To investigate effectiveness of percutaneous posterior tibial nerve stimulation (PTNS) in MS patients suffering from FI and FC. Methods: Prevalence and severity of FI and FC were prospectively collected among MS patients undergoing 12 weeks of PTNS for neurogenic bladder. The Cleveland Clinic Fecal Incontinence Score (CCFIS) and the Rome III criteria were used to define FI and FC, respectively. Subjective treatment satisfaction was estimated using the Benefit Satisfaction and Willingness to Continue (BSWC) questionnaire. Results: A total of 60 patients undergoing PTNS suffered from NBDs (25 FI+/FC+, 5 FI+/FC–, 30 FI–/FC+). Median CCFIS decreased after PTNS from 12.0 (11.0–13.0) to 8.5 (7.0–11.0, p < 0.001), with particular improvements in liquid and flatal incontinence, pads’ need, and lifestyle restrictions. Seven patients became FC free after PTNS and no patients developed FC during the study ( p = 0.023). More than 50% of the patients were satisfied and willing to continue PTNS at study end. Conclusion: PTNS represents a valid minimally invasive alternative treatment for MS patients suffering from NBDs.

Sign in / Sign up

Export Citation Format

Share Document